| abstract |
The present invention relates to compounds of formula (I) wherein the substituents are as described herein, and are used in conjunction with a potential-gated sodium channel (VGSC), particularly NaV.n1.7 The use of a drug for inhibiting the treatment of a disease or disorder associated with it. It is further related to the treatment of potential gated sodium channels (VGSC), especially NaVnA compound of the formula 1.7, which is effective for inhibiting a disease, disorder, condition and/or symptom associated with it, and a pharmaceutically acceptable salt thereof, a pharmaceutical composition thereof. The invention is also related to the preparation of the compounds of the invention. □ |